| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 Oct 2026 | 16 Oct 2026 |
| Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve The Company has enclosed herewith intimation for Board Meeting to be held on 29.10.2026 inter-alia, to consider and adopt the unaudited financial results for the 2nd quarter and half year ended September 30, 2026 Outcome of the Board Meeting for consideration of unaudited financial results for the quarter ended 30.09.2026 (As per BSE Announcement dated on: 29.10.2026) | ||
| Board Meeting | 6 Aug 2026 | 28 Jul 2026 |
| Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Intimation of Board Meeting to be held on 6th Agust 2026 interalia to consider and approve unaudited financial results for the quarter ended 30th June 2026. Outcome of BM (As Per BSE Announcement Dated on: 06/08/2026) | ||
| Board Meeting | 26 Jun 2026 | 26 Jun 2026 |
| Outcome of Board Meeting | ||
| Board Meeting | 21 May 2026 | 7 May 2026 |
| Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that meeting of the Board of Directors of the Company will be held on Thursday, May 21, 2026, inter-alia, to consider and adopt the audited financial results for the 4th quarter and financial year ended March 31, 2026. Outcome of Board Meeting 21.05.2026 (As per BSE Announcement dated on: 21.05.2026) | ||
| Board Meeting | 9 Feb 2026 | 14 Jan 2026 |
| Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Board Meeting intimation to consider and adopt the unaudited financial results for the 3rd quarter and nine months ended December 31 2025. Outcome of Board Meeting. (As per BSE announcement dated on : 09.02.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
